Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference
Provided By GlobeNewswire
Last update: Nov 18, 2025
JERUSALEM, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (Nasdaq: ENTX), (“Entera” or the “Company”) a leader in the development of oral peptide and protein replacement therapies, today announced that the Company’s Chief Executive Officer, Miranda Toledano, will be participating in a fireside chat at the 8th Annual Evercore ISI Healthcare Conference, details as below.
Read more at globenewswire.com
